The cardiovascular safety of methylphenidate

BMJ. 2016 May 31:353:i2874. doi: 10.1136/bmj.i2874.

Author

John W Jackson¹

Affiliation

¹ Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Abstract

What to make of studies that agree to disagree

Publication types

Editorial

MeSH terms

Attention Deficit Disorder with Hyperactivity / drug therapy
Attention Deficit Disorder with Hyperactivity / epidemiology
Cardiovascular Diseases* / classification
Cardiovascular Diseases* / epidemiology
Central Nervous System Stimulants / therapeutic use
Child
Comorbidity
Humans
Methylphenidate / therapeutic use*
Republic of Korea / epidemiology
Risk Assessment / methods
Risk Factors

Substances

Central Nervous System Stimulants
Methylphenidate